{"podcast":{"title":"DX Today | No-Hype Podcast & News About AI & DX","slug":"dx-today-no-hype-podcast-news-about-ai-dx-6434212","podcast_index_feed_id":6434212,"rss_url":"https://rss.buzzsprout.com/2207817.rss","website_url":"https://dxtoday.com/free-dxt-podcast","image_url":"https://storage.buzzsprout.com/dwohat9h5b61o3j3b9bhs8v3q3f1?.jpg","author":"Rick Spair","episode_count":584,"summary":"The DX Today Podcast: Real Insights About AI and Digital Transformation Tired of AI hype and transformation snake oil? This isn't another sales pitch disguised as expertise. Join a 30+ year tech veteran and Chief AI Officer who's built $1.2 billion in real solutions—and has the battle scars to prove it. No vendor agenda. No sponsored content. Just unfiltered insights about what actually works in AI and digital transformation, what spectacularly fails, and why most \"expert\" advice misses the mark. If you're looking for honest perspectives from someone who's been in the trenches since before \"digital transformation\" was a buzzword, you've found your show. Real problems, real solutions, real talk. For executives, practitioners, and anyone who wants the truth about technology without the sales pitch.","last_synced_at":"2026-06-17T22:17:32.828784+00:00","page_url":"https://stenobird.com/podcast/dx-today-no-hype-podcast-news-about-ai-dx-6434212"},"episode":{"title":"Novo Nordisk and OpenAI: End to End Pharma AI, the GLP One Race, and the Regulatory Crucible Ahead - May 3, 2026","slug":"novo-nordisk-and-openai-end-to-end-pharma-ai-the-glp-one-race-and-the-regulatory-crucible-ahead-may-3-2026","published_at":"2026-05-03T10:10:14+00:00","page_url":"https://stenobird.com/podcast/dx-today-no-hype-podcast-news-about-ai-dx-6434212/novo-nordisk-and-openai-end-to-end-pharma-ai-the-glp-one-race-and-the-regulatory-crucible-ahead-may-3-2026","show_page_url":"https://stenobird.com/podcast/dx-today-no-hype-podcast-news-about-ai-dx-6434212","url":"https://www.buzzsprout.com/2207817/episodes/19115097-novo-nordisk-and-openai-end-to-end-pharma-ai-the-glp-one-race-and-the-regulatory-crucible-ahead-may-3-2026.mp3","audio_url":"https://www.buzzsprout.com/2207817/episodes/19115097-novo-nordisk-and-openai-end-to-end-pharma-ai-the-glp-one-race-and-the-regulatory-crucible-ahead-may-3-2026.mp3","summary":"Send us Fan Mail Novo Nordisk and OpenAI: End to End Pharma AI, the GLP One Race, and the Regulatory Crucible Ahead - May 3, 2026 The Danish drugmaker behind Ozempic and Wegovy is integrating OpenAI's models across drug discovery, clinical trials, manufacturing, supply chain, and commercial operations, with pilots in twenty twenty six and full integration by year end. Rick Spair and Laura unpack what is real, what is theater, and what the deal signals for the rest of regulated industry. Hos...","meta_description":"Send us Fan Mail Novo Nordisk and OpenAI: End to End Pharma AI, the GLP One Race, and the Regulatory Crucible Ahead - May 3, 2026 The Danish drugmaker beh…","key_points":[],"chapters":[],"topics":[],"duration_seconds":823,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/dx-today-no-hype-podcast-news-about-ai-dx-6434212/episodes/novo-nordisk-and-openai-end-to-end-pharma-ai-the-glp-one-race-and-the-regulatory-crucible-ahead-may-3-2026/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/dx-today-no-hype-podcast-news-about-ai-dx-6434212/novo-nordisk-and-openai-end-to-end-pharma-ai-the-glp-one-race-and-the-regulatory-crucible-ahead-may-3-2026.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}